Study Information
Study Details
View study details on clinicaltrials.gov.
Locations
Clinical Trial FAQs
Information for patients and study volunteers, including frequently asked questions.
Description
This is an open-label, phase 2 study that aims to evaluate the efficacy and safety/tolerability of ceralasertib, when administered as monotherapy and in combination with durvalumab in participants with unresectable or advanced melanoma and primary or secondary resistance to PD-(L)1 inhibition.
Location: SIMR (Sacramento/Valley Area, Roseville, and Auburn)
Please contact: SIMR@sutterhealth.org about Metastatic (AstraZeneca D533AC00001 MONETTE)
Principal Investigator
Co-Investigator(s)
Sivakumar Reddy, M.D., Kristie A. Bobolis, M.D., Vijay Suhag, M.D., Dron Gauchan, MD, Kristin N. Arreola, M.D., Rajeswari Chellappah, M.D., Jaspreet K Dhillon, Medical Oncologist, Brian K. Kim, M.D
Related Studies
Cancer Liquid Biopsy Monitoring Study
Investigators: Mohammed Kashani-Sabet, M.D., Deepti Behl, MD
COVID-19 Impacts on Cancer Care Management, Patient Experience and Care Costs
Investigators: Cheryl Stults, Ph.D., Su-Ying Liang, Ph.D., Monique de Bruin, M.D., MPH
Stupski Serious Illness Program Evaluation
Investigator: Sylvia Sudat, PhD
Impact of COVID-19 on Cancer Care Management
Investigators: Monique de Bruin, M.D., MPH, Su-Ying Liang, Ph.D.
Coverage, Price, and Reimbursement for Multigene Tests for Cancer and Related Conditions
Investigator: Su-Ying Liang, Ph.D.
Improving Cancer Care
Investigator: Su-Ying Liang, Ph.D.
Multilevel Study of Lung Cancer Screening Guidelines Implementation (MUST)
Investigator: Jiang Li, Ph.D., MPH
Implementing Universal Lynch Syndrome Screening Across Multiple Healthcare Systems: Identifying Strategies to Facilitate and Maintain Programs in Different Organizations Contexts
Investigators: Monique de Bruin, M.D., MPH, Su-Ying Liang, Ph.D., External PI, Principal Investigator
Lung Cancer in Never Smokers: Incidence, Risk Factors and Molecular Characteristics in Asian American, Native Hawaiian, and Pacific Islander (AANHPI) Women
Investigators: Su-Ying Liang, Ph.D., External PI, Principal Investigator